title: Biomaterials in cardiopulmonary bypass.
abstract: The improved utilization of biomaterials in cardiopulmonary bypass is dependent on polymer science and technology, procedures for blood compatibility assessment, optimization of biomaterial/antithrombotic agent combinations and the interpretation of clinical data.
authors.affiliation: Bioengineering Unit, University of Strathclyde, Glasgow, UK.
authors.forename: J M
authors.initials: JM
authors.lastname: Courtney
authors.forename: S
authors.initials: S
authors.lastname: Sundaram
authors.forename: B M
authors.initials: BM
authors.lastname: Matata
authors.forename: J D
authors.initials: JD
authors.lastname: Gaylor
mesh_terms: D001672:Biocompatible Materials / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006355:Heart-Lung Machine; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D013927:Thrombosis / Q000209:etiology
chemical_list: D001672:Biocompatible Materials; D005343:Fibrinolytic Agents